Drugs of the Future
Last updated ISSN 0377-8282
Drugs of the Future is published by Thomson Reuters in medicine. It is a subscription journal. Its article processing charge is not published.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Drugs of the Future is — and show you journals like it.
What it publishes
Recent work in Drugs of the Future concentrates on these topics, taken from its published record rather than from its own description:
- Cancer Treatment and Pharmacology
- Drug-Induced Ocular Toxicity
- Drug-Induced Adverse Reactions
- Chronic Lymphocytic Leukemia Research
- Advanced Breast Cancer Therapies
- Blood disorders and treatments
- Pharmacological Effects and Toxicity Studies
- Chemotherapy-related skin toxicity
- Poisoning and overdose treatments
- Antibiotics Pharmacokinetics and Efficacy
Key facts
| Publisher | Thomson Reuters |
|---|---|
| ISSN | 0377-8282, 2013-0368 |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | Not published |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 6,527 |
| Publishing since | 1976 |
| Journal website | journals.prous.com/journals/servlet/xmlxsl/pk_journa |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Drugs of the Future
Other established journals in medicine, if this one is not the right home for your paper: